Recruiting

NCT Number: NCT06808295

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Patients Undergoing External Dacrocystorhinostomy Operations Assess Decreased Anesthetic Requirements Intraoperative

Age range

16 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Research Institute of Ophthalmolgy

Giza, Egypt

Location status: Recruiting

About this study

Dexmedetomidine is a highly selective alpha 2 adrenoceptor agonist, having characteristics of natural sleep like sedation, can reduce pain intensity and opioid consumption without influencing the time of recovery from general anesthesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III

Exclusion criteria

Pediatric age group
ASA more than III

Treatment and study plan

Dexmedetomidine Hydrochloride

Drug

drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative

Primary outcomes

Maintained hemodynamic values while reducing the anesthetic requirements

Time frame: from 20 minutes after administering the drug till 2 hours after full recovery

Measuring the heart rate and the blod pressure every 5 minutes intraoperative and for half an hour postoperative to assess hemodynamic stability

Secondary outcomes

Delerium

Time frame: from 20 minutes after administering the drug till 2 hours after full recovery

Reducing postoperative delirium in elderly patients

Study contacts

Contact information is provided by the study sponsor or research team.

Dina Moustafa Mohamed Ali, MD

CONTACT

[email protected]

01113981021

Sponsors and collaborators

Lead sponsor

Research Institute of Ophthalmology, Egypt

Other

Registry information

Official study title

Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study

Acronym: DCR

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2025
First posted: Feb 5, 2025
Registry last updated: Feb 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.